𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ductal carcinoma in situ of the breast and heparanase-1 expression: A molecular explanation for more aggressive subtypes

✍ Scribed by Justin B. Maxhimer; Catherine E. Pesce; Robyn A. Stewart; Paolo Gattuso; Richard A. Prinz; Xiulong Xu

Book ID
113676381
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
454 KB
Volume
200
Category
Article
ISSN
1072-7515

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Aberrant expression of muc1 mucin in duc
Aberrant expression of muc1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast
✍ Ellen C.M. Mommers; Angelique M. Leonhart; Silvia von Mensdorff-Pouilly; Dick J. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 91 KB πŸ‘ 2 views

MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought

A prognostic index for ductal carcinoma
A prognostic index for ductal carcinoma in situ of the breast
✍ Melvin J. Silverstein; Michael D. Lagios; Pamela H. Craig; James R. Waisman; Ber πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 663 KB

## BACKGROUND. There is controversy and confusion regarding therapy for patients with ductal carcinoma in situ (DCIS) of the breast. The Van Nuys Prognostic Index (VNPI) was developed to aid in the complex treatment selection process.